Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01309100 · ClinicalTrials.gov registry record · NA

Product Feasibility of a New Silicone Hydrogel Contact Lens

A NA study, sponsored by Bausch & Lomb Incorporated.

Completed
Registry status
NA
Development phase
144
Enrollment target

NCT01309100: Completed NA study, sponsored by Bausch & Lomb Incorporated.

NCT01309100 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 144 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01309100, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.

COMPLETED
Registry status
NA
Development phase
144 participants
Enrollment target

Study Summary

The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lens.

Primary Outcome

The mean difference in distance high contrast logMAR visual acuity(VA) between the investigational lens (RD2117-01) and the Air Optix Aqua control lens.

Interventions

  • DEVICE Investigational Lens
  • DEVICE Acuvue Oasys Lens
  • DEVICE Air Optix Aqua Lens

Trial Details

FieldValue
Enrollment Target 144 participants
Start Date 2010-11
Est. Completion 2011-01
Phase NA
Bausch & Lomb Incorporated

174 total trials

What the finished NCT01309100 record still lists

NCT01309100 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).

The record links to 0 conditions, and to 3 interventions - of which Investigational Lens is the first listed.

NCT01309100 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01309100 about?

NCT01309100 is a clinical study titled "Product Feasibility of a New Silicone Hydrogel Contact Lens". The objective of this study is to determine the clinical feasibility and to evaluate the product performance of investigational contact lens.

What is the current status of trial NCT01309100?

This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2010-11. Estimated completion is 2011-01.

What interventions are being tested in trial NCT01309100?

The interventions under investigation include: Investigational Lens (DEVICE), Acuvue Oasys Lens (DEVICE), Air Optix Aqua Lens (DEVICE).

Who is sponsoring clinical trial NCT01309100?

This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01309100's enrollment target sits among peer trials

144 706th of 2000 higher than 1,290 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01861106 · 144 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

  • NCT03482245 · 144 participants · NA

    The Role of Circadian Clock Proteins in Innate and Adaptive Immunity

  • NCT03504683 · 144 participants · NA

    MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes

  • NCT03905603 · 144 participants · Early Phase 1

    Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01309100, the US trial registry maintained by the National Library of Medicine. NCT01309100 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.